A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2021; you can also visit the original URL.
The file type is application/pdf
.
TOMOGRAFÍA DE COHERENCIA ÓPTICA COMO MARCADOR PARA LAS ENFERMEDADES NEURODEGENERATIVAS DE ALZHEIMER Y PARKINSON
OPTICAL COHERENCE TOMOGRAPHY AS A MARKER FOR NEURODEGENERATIVE ALZHEIMER'S AND PARKINSON'S DISEASE
2021
Revista Medica Vozandes
OPTICAL COHERENCE TOMOGRAPHY AS A MARKER FOR NEURODEGENERATIVE ALZHEIMER'S AND PARKINSON'S DISEASE
Optical coherence tomography (OCT) is an ancillary test used in retinal pathology. The objective of the present dissertation is to review literature regarding (OCT) and its importance as a biomarker in neurodegenerative Alzheimer's and Parkinson's disease, through an analysis of medical journal articles published between 2015 and 2019. Methods: A retrospective systematic review without meta-analysis of literature was carried out using observational research design, allowing to summarize the
doi:10.48018/rmv.v32.i1.4
fatcat:umjhl6th2vfgriecpihskdatta